Evidence map›Paper›PMID 21273480›Full record

ArticleScience (New York, N.Y.)2011

Rapid pneumococcal evolution in response to clinical interventions.

Nicholas J Croucher, Simon R Harris, Christophe Fraser, Michael A Quail, John Burton, Mark van der Linden, Lesley McGee, Anne von Gottberg, Jae Hoon Song, Kwan Soo Ko and 13 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 589 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
589citing papers in PubMed, 1 pooled it
68.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

589 citing papers in PubMed, 1 synthesis or guideline pooled it, 904 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Artificial Intelligence-Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genomic epidemiology ofFrontiers in cellular and infection microbiology · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Change in the distribution ofFrontiers in microbiology · 2026
    Article
  18. Article
  19. Article
  20. A tripartite protein complex promotes DNA transport during natural transformation in Firmicutes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

529 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 5 countries.

Nicholas J CroucherThe Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Simon R Harris
Christophe Fraser
Michael A Quail
John Burton
Mark van der Linden
Lesley McGee
Anne von Gottberg
Jae Hoon Song
Kwan Soo Ko
Bruno Pichon
Stephen Baker
Christopher M Parry
Lotte M Lambertsen
Dea Shahinas
Dylan R Pillai
Timothy J Mitchell
Gordon Dougan
Alexander Tomasz
Keith P Klugman
Julian Parkhill
William P Hanage
Stephen D Bentley
Wellcome Sanger Institute · GBCenters for Disease Control and Prevention · USHospital for Tropical Diseases · VNImperial College London · GBSungkyunkwan University · KRStatens Serum Institut · DKUniversity of Glasgow · GB

Funding

Medical Research Council G0800596Wellcome Trust 076962Wellcome Trust 076964
6 · The paper itself

Abstract

Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.

Indexed as

Evolution, MolecularRecombination, GeneticAdaptation, PhysiologicalAnti-Bacterial AgentsAntigenic VariationDNA Transposable ElementsDrug Resistance, Multiple, BacterialGenome, BacterialHumansMolecular EpidemiologyPhylogenyPhylogeographyPneumococcal InfectionsPneumococcal VaccinesPolymorphism, Single NucleotideProphagesAnti-Bacterial AgentsDNA Transposable ElementsPneumococcal Vaccines

Identifiers

PMID21273480
PMCPMC3648787
OpenAlexW2037409969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.